|
Retrodifferentiation Technology
Introduction

TriStem’s unique patented Retrodifferentiation technology is based
on the results of 15 years of research. The main advantage of
TriStem's pioneering and patented process over existing methods of
harvesting stem cells is that it obviates the need to use human
donor cells, embryos or foetuses and, therefore, bypasses the
controversial process of therapeutic cloning, is cost effective and
provides large quantities of stem cells which are by definition DNA
matched.
|